FDA.reportPublic FDA data

Application 202168

Type
ANDA
Sponsor
CADILA PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ACYCLOVIRACYCLOVIRTABLET;ORAL400MGNoNo
002ACYCLOVIRACYCLOVIRTABLET;ORAL800MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
53002-0080AcyclovirAcyclovirRPK Pharmaceuticals, Inc.ANDACurrent
53002-0080AcyclovirAcyclovirRPK Pharmaceuticals, Inc.ANDACurrent
53002-0081AcyclovirAcyclovirRPK Pharmaceuticals, Inc.ANDACurrent
53002-0081AcyclovirAcyclovirRPK Pharmaceuticals, Inc.ANDACurrent
67296-1625AcyclovirAcyclovirRedPharm Drug, Inc.ANDACurrent
67296-1625AcyclovirAcyclovirRedPharm Drug, Inc.ANDACurrent
68071-4345AcyclovirAcyclovirNuCare Pharmaceuticals,Inc.ANDACurrent
71209-005AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-005AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-005AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-005AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-006AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-006AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-006AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
71209-006AcyclovirAcyclovirCadila Pharmaceuticals LimitedANDACurrent
72241-026AcyclovirAcyclovirModavar Pharmaceuticals LLCANDACurrent
72241-026AcyclovirAcyclovirModavar Pharmaceuticals LLCANDACurrent
72241-027AcyclovirAcyclovirModavar Pharmaceuticals LLCANDACurrent
72241-027AcyclovirAcyclovirModavar Pharmaceuticals LLCANDACurrent
75834-122AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent
75834-122AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent
75834-122AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent
75834-123AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent
75834-123AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent
75834-123AcyclovirAcyclovirNivagen Pharmaceuticals, Inc.ANDACurrent